Oura, a company known for its connected rings that track health metrics, has postponed its initial public offering (IPO), which was originally set for September 21. The IPO was intended to be listed on the Nasdaq, a major stock exchange in the United States that focuses on technology companies. Oura cited market uncertainties as the reason for the delay, even though the company reported "strong demand" for its shares. The company had planned to sell 50 million shares at a price between $40 and $44, aiming to raise $2.2 billion in total. The decision to delay the IPO came just a week after the company announced the planned launch. This delay is notable because the stock market challenges Oura mentioned are not new, and similar issues have affected other companies attempting to go public. Tom Hale, Oura's CEO, said the company wants to ensure a successful IPO for its employees and investors. He emphasized that the company has the flexibility to choose the best timing and will continue to look for opportunities as they arise. Oura is described as a profitable company, with its growth further supported by the recent IPO planning process. The Oura 5 ring, one of the company's products, has received "an exceptional reception" from users. The company currently has 5.7 million paying subscribers, each paying a monthly fee of €5.99. These subscribers contribute to the company's financial success, with revenue expected to grow by 90% compared to the same period last year. Despite the delay, Oura remains confident in its market position and future prospects. The company has moved its legal headquarters to the United States this year, although its research and development still takes place in Finland. This strategic move may help the company better navigate the U.S. market, where it plans to raise significant capital through its IPO. Oura's ability to adapt and make strategic decisions is seen as a key factor in its continued success.